Please login to the form below

Not currently logged in
Email:
Password:

RENOIR

This page shows the latest RENOIR news and features for those working in and with pharma, biotech and healthcare.

Pfizer receives Breakthrough Therapy Designation from FDA for RSV vaccine candidate

Pfizer receives Breakthrough Therapy Designation from FDA for RSV vaccine candidate

Pfizer announced the launch of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunised against RSV disease) in September 2021 – a phase 3 clinical trial evaluating the efficacy, immunogenicity, and safety of

Latest news

  • Pfizer starts RSV trial ahead of winter season Pfizer starts RSV trial ahead of winter season

    The RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV disease) phase 3 trial will study the efficacy, immunogenicity and safety of a single dose in 30, 000 participants during

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Origins Insights

Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....